18 results
8-K
EX-10.1
ITCI
Intra-Cellular Therapies Inc
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
.
13.2.5 Disputed Breach. If ITI disputes in good faith the existence or materiality of a breach specified in a notice provided by BMS pursuant to Section … disputes in good faith the existence or materiality of such breach and provides notice to ITI of such dispute within such [***] ([***]) [***] period
PRE 14A
zdpcm
19 Apr 21
Preliminary proxy
5:28pm
424B3
gdoq5s
19 Dec 13
Prospectus supplement
12:00am
8-K/A
EX-10.1.1
551ei5
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
gvi47
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
S-1
p8hk514l0dmeay
18 Sep 13
IPO registration
12:00am
8-K
0dme 6fji
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.1.1
xzrzfp78
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
4b7cvn nnj6u
29 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
lef gazdv
29 Aug 13
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next